Given that mitochondrial dysfunction in tauopathies was identified already at early disease stages, occurring even before the onset of cognitive deficits [17], recent publications have focused on studying the relationship between tau and mitochondria in human iPSC-derived neurons from patients bearing different MAPT mutations. The gene discussed is MAPT; the disease is Cognitive impairment.